Center-Authored Papers

Filters: Author is Freudenheim, Jo L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
B
H
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender BJ, Segal B, Odunsi K, Mayor P, Diergaarde B et al..  2017.  History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(9):1470-1473. Abstract
I
Millen AE, Pettinger M, Freudenheim JL, Langer RD, Rosenberg CA, Mossavar-Rahmani Y, Duffy CM, Lane DS, McTiernan A, Kuller LH et al..  2009.  Incident invasive breast cancer, geographic location of residence, and reported average time spent outside.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(2):495-507. Abstract
N
S
T
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, Wolk A, Wentzensen N, Weiss NS, Webb PM et al..  2013.  Type I and II Endometrial Cancers: Have They Different Risk Factors? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20):2607-18. Abstract
U
Brasky TM, Krok-Schoen JL, Liu J, Chlebowski RT, Freudenheim JL, Lavasani S, Margolis KL, Qi L, Reding KW, Shields PG et al..  2017.  Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(8):1345-1348. Abstract
Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, Trevisan M, Edge SB, Freudenheim JL.  2012.  Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(1):239-42. Abstract